A blood test could determine whether a feverish baby has a bacterial or viral infection in 15 to 20 minutes. This would help doctors gauge whether the infection is serious or may pass without treatment, which could prevent unnecessary use of antibiotics.
When babies are brought into hospital with fever, they 鈥渁re considered high-risk until proven otherwise鈥�, says at the Giannina Gaslini Institute in Genoa, Italy.
A fever can be the result of several things, including infection by viruses or bacteria. These different types of pathogens require different medications. Furthermore, most common viruses are fairly benign, while bacterial infections are generally more dangerous, says Bellini.
Advertisement
Existing tests to gauge infection type take at least a few hours, so babies with fever are often given antibiotics against bacteria as a precautionary measure. But only about 15 per cent of them actually have a serious bacterial infection, says Bellini. This unnecessary use of antibiotics helps drive the spread of bacterial resistance.
To develop a test that determines infection type, Bellini and his colleagues followed 85 babies, all younger than 90 days old, who were brought into emergency rooms with fever after previously having no serious health concerns. The team took blood samples and tested for two proteins: CD64 and CD169.
Previous studies have shown that these proteins become more common in certain blood cells when the body responds to infections. CD64 is made at higher levels in response to bacteria and is found on the surface of white blood cells called neutrophils. and appears on the outer membranes of monocytes, another type of white blood cell.
By in neutrophils and monocytes, the test correctly identified all 15 cases of bacterial infection, 44 incidences of viral infection and 26 cases of no infection. Bellini presented the results at the in Paris, France.
The results came through in 15 to 20 minutes in a lab, says Bellini, who is trying to develop a version that can be used as quickly in hospitals.
This builds on several years of research to develop a CD64/CD169 test. at Beckman Coulter Life Sciences in Marseille, France, has spent much of the past decade working on it. In 2021, his team found that among adults in an emergency room.
Other groups have since , found ways to more , and demonstrated that . Performing the test on babies in a hospital setting is a significant advance, says Malergue. It was crucial to investigate the test in this age group because their immune systems are still developing, which meant 鈥渟ome people had doubts about the capacity of these [CD64 and CD169] markers to arise鈥�, he says.
Malergue says one of his collaborators used the test in Martinique during an outbreak of dengue fever, which is caused by a virus and is usually mild. The collaborator found that some people actually had a bacterial infection called leptospirosis, which is life-threatening without antibiotics.
Bellini now hopes to assess the test in a trial of 300 to 500 infants at multiple hospitals. Meanwhile, Malergue and his colleagues have developed that can quickly analyse finger-prick blood samples to determine whether an infection is viral or bacterial, which is approved for research use.
